Explore the Agenda
8:00 am Registration & Morning Coffee
9:00 am Workshop A – If You’re Not Measuring It, It Didn’t Happen: Building Sustainable, Cross- Functional Systems for Patient Engagement Across Long-Term Trials
Sustaining patient engagement measurement across multi-year programs is increasingly difficult as teams shrink, roles evolve, and priorities shift. This interactive workshop focuses on how to protect measurement continuity, credibility, and impact through organizational change – combining cross-functional systems thinking with practical strategies for adapting when resources are constrained. Participants will explore how to align stakeholders, leverage existing tools, and evolve their approach without losing momentum or trust.
This Workshop Will Gather Experts to Discuss:
- Designing cross-functional processes that sustain measurement across departments and long-term trials
- Leveraging existing technology and systems to capture engagement metrics efficiently
- Maintaining shared accountability across patient advocacy, clinical, medical, and commercial teams
- Prioritizing meaningful, defensible metrics that demonstrate impact on patient experience and trial outcomes
- Adapting measurement approaches during organizational change, budget pressure, or shifting priorities
12:00 pm Lunch Break & Networking
1:00 pm Workshop B – Patient Engagement & Patient Experience Data in the Current Global Regulatory Landscape
Patient experience data (PED) is transforming how therapies are developed and evaluated – but regulatory expectations are evolving rapidly. This interactive workshop provides practical insights into global regulatory requirements and strategies to maximize the impact of patient engagement throughout the product development lifecycle.
This Workshop Will Gather Experts to Discuss:
- Understanding current PED expectations from regulators by exploring FDA, EMA, and MHRA requirements for patient experience data in drug development
- Leveraging early dialogues with regulators by engaging them early to shape development strategies with patient insights
- Reviewing case examples of patient engagement impact by analyzing real-world examples showing how patient engagement influences drug development and regulatory decisions
- Examining recent regulatory developments by assessing EMA’s reflection paper and FDA initiatives and applying insights to real-world scenarios
- Collaborating on optimizing patient experience data across the lifecycle by developing strategies to effectively collect, analyze, and apply patient experience data from early development through treatment